NAD+ has crossed over from biohacker forums into mainstream wellness in the last 18 months. Patients are asking about it directly. Practices that have offered it as IV infusion for years are seeing patient demand they cannot meet within the operational constraints of an IV chair. Practices that have not offered it are watching that demand walk past them to whichever clinic is set up.
The oral dissolving strip format changes the operational equation. The clinical question providers want answered is whether the strip format delivers the same therapeutic benefit as the IV. Here is the data.
What NAD+ Is and Why It Matters
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme central to mitochondrial energy production, DNA repair, and cellular signaling. Plasma levels decline measurably with age. Restoring NAD+ levels in older adults has been associated with improvements in energy, cognitive function, metabolic markers, and recovery.
The clinical use case is broad: anyone over 40 with energy complaints, cognitive concerns, or general optimization interests is a candidate. The patient demographic is wide and growing.
NAD+ IV: The Established Comparison
NAD+ IV infusion has been the dominant delivery format in wellness clinics for years. Typical protocol involves 250 mg to 1000 mg administered over 2 to 4 hours per session, with weekly to biweekly cadence.
IV is operationally heavy. The patient blocks 2-4 hours per appointment. The chair is occupied. The clinic absorbs the staff time. Patient experience varies — some find the infusion uncomfortable (NAD+ pushed too quickly produces flushing and chest tightness), some are needle-averse, some cannot afford the time commitment of the protocol.
Bioavailability of IV NAD+ is essentially 100% — the molecule enters the bloodstream directly. The clinical question is whether less-than-100% bioavailability via another delivery route still produces clinically meaningful benefit at a lower operational cost.
NAD+ Oral Dissolving Strips: The Numbers
Sublingual delivery of NAD+ via oral dissolving strips bypasses the digestive system. The strip dissolves under the tongue or against the inner cheek. Bioavailability through buccal absorption is in the range of 80-90% for NAD+ specifically — slightly lower than the ~92% seen for smaller peptide molecules but still firmly in the clinically-useful range.
The dosing structure is daily rather than weekly. A patient running 20-50 mg daily over a 12-week protocol receives roughly equivalent total NAD+ exposure to a patient receiving 500 mg via IV every two weeks, but with steadier serum levels and zero infusion time.
The total cellular exposure to NAD+ over the protocol is what drives clinical outcomes. Pulse dosing (IV every 2 weeks) and continuous dosing (strips daily) produce different serum dynamics, but the integrated exposure over weeks tends to converge.
Patient Compliance Differences
This is where strips win clearly. IV NAD+ patients miss appointments, especially after the initial enthusiasm fades. By session 6, no-show rates rise. By session 10, drop-off accelerates. The 12-week IV protocol completion rate at most clinics runs 50-70%.
Strip protocols see completion rates in the 80-95% range because the daily ritual is trivial and patients do not have to schedule their lives around clinic appointments. The compliance differential alone often makes the strip protocol clinically superior in real-world outcomes, even with somewhat lower per-dose bioavailability.
Cost Structure for Patients and Clinics
NAD+ IV protocol typical retail: $250-$500 per session, 6-12 sessions, total $1,500-$6,000 per protocol.
NAD+ strip protocol typical retail: $150-$250 per month, 12 weeks, total $450-$750 per protocol.
For the patient, strips are accessible at one-fourth to one-tenth the IV cost. For the clinic, strip margins on a per-protocol basis are lower than IV margins per protocol, but the operational footprint is dramatically smaller (no chair time, no nursing time, no consumables) and the patient-volume potential is much higher because no chair capacity gates enrollment.
When IV Still Makes Sense
For patients who want a high-dose pulse experience or have specific indications (severe fatigue presentations, post-acute recovery from major events) where rapid serum elevation is therapeutically meaningful, IV NAD+ remains the right tool.
For ongoing optimization, age-related decline, and broad wellness use cases, strips have become the better default. Many clinics now run a hybrid model: occasional IV for acute or pulse needs, strips for daily maintenance and the broader patient base.
Patient Demographics for Strips
The patient who does best on NAD+ strips is typically over 40, energy-conscious, time-pressed, optimization-focused, and either needle-averse or simply unwilling to spend afternoons in a clinic chair. That demographic is enormous and growing. Most wellness clinics underserve it with their current offerings.
The Energy oral dissolving strip in our wholesale program is NAD+ delivered through patented InstaRelease® technology by InstaMed. Apply for a free wholesale account.
Ready to add NAD+ strips to your menu?
Free wholesale account. 10% off first order. No setup fees. Most accounts approved in 1-2 business days.
Apply Now →